Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study
- PMID: 37269443
- PMCID: PMC10239215
- DOI: 10.1007/s11096-023-01604-x
Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study
Abstract
Background: Pharmacists have been co-located in general practice teams to support the quality use of medicines and optimise patient health outcomes. Evidence of the impact of pharmacist-led activities in Australian general practices is sparse.
Aim: This study aimed to evaluate the potential outcomes of pharmacist-led activities in Australian general practices.
Method: A prospective observational study was conducted in eight general practices in the Australian Capital Territory, where each general practice employed a pharmacist on a part-time basis for 18 months. A recommended, but flexible, list of activities was provided for pharmacists. Descriptive information on general practice pharmacist-led activities, collected with an online diary, was analysed. The potential clinical, economic, and organisational impact of pharmacist-led clinical activities was evaluated using the CLinical Economic Organisational (CLEO) tool, with a modified economic dimension.
Results: Nine pharmacists reported 4290 activities over 3918.5 work hours in general practice. Medication management services were the primary clinical activity of pharmacists. In medication reviews, 75% of the pharmacists' recommendations were fully accepted by general practitioners. Conducting clinical audits, updating patients' medical records, and providing information to patients and staff were other major activities of pharmacists. Of 2419 clinical activities, around 50% had the potential for a moderate or major positive clinical impact on patients. Sixty-three per cent of activities had the potential to decrease healthcare costs. Almost all the pharmacist-led clinical activities had a positive organisational impact.
Conclusion: Most pharmacist-led clinical activities in general practice had the potential for a positive impact on patients and reduction in healthcare costs, supporting the expansion of this model in Australia.
Keywords: Clinical activities; Clinical impact; Economic impact; Evaluation; General practice pharmacist; Medicines; Organisational impact.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interests.
Similar articles
-
Enhanced primary care after hospitalization: General practitioner, pharmacist and patient feedback from the REMAIN HOME trial.Res Social Adm Pharm. 2023 Mar;19(3):510-516. doi: 10.1016/j.sapharm.2022.09.014. Epub 2022 Oct 1. Res Social Adm Pharm. 2023. PMID: 36261303
-
General practitioners' perceptions of pharmacists working in general practice: a qualitative interview study.Fam Pract. 2023 Mar 28;40(2):377-386. doi: 10.1093/fampra/cmac115. Fam Pract. 2023. PMID: 36242543 Free PMC article.
-
What can pharmacists do in general practice? A pilot trial.Aust J Gen Pract. 2018 Aug;47(8):545-549. doi: 10.31128/AJGP-03-18-4520. Aust J Gen Pract. 2018. PMID: 30114892
-
General practice pharmacists in Australia: A systematic review.PLoS One. 2021 Oct 14;16(10):e0258674. doi: 10.1371/journal.pone.0258674. eCollection 2021. PLoS One. 2021. PMID: 34648595 Free PMC article.
-
A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.Fam Pract. 2021 Jul 28;38(4):509-523. doi: 10.1093/fampra/cmaa146. Fam Pract. 2021. PMID: 33506870
Cited by
-
Potential roles for pharmacists within youth mental health services: A qualitative exploration of staff views.Explor Res Clin Soc Pharm. 2024 Jul 17;15:100480. doi: 10.1016/j.rcsop.2024.100480. eCollection 2024 Sep. Explor Res Clin Soc Pharm. 2024. PMID: 39157070 Free PMC article.
-
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists' perceptions and experiences.Int J Clin Pharm. 2025 Apr 28. doi: 10.1007/s11096-025-01913-3. Online ahead of print. Int J Clin Pharm. 2025. PMID: 40293643
-
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions.Int J Clin Pharm. 2025 Feb;47(1):119-127. doi: 10.1007/s11096-024-01813-y. Epub 2024 Oct 4. Int J Clin Pharm. 2025. PMID: 39365523
-
Pharmacists in general practice: what do they do? A qualitative case study.Int J Clin Pharm. 2023 Dec;45(6):1472-1482. doi: 10.1007/s11096-023-01619-4. Epub 2023 Aug 12. Int J Clin Pharm. 2023. PMID: 37573267 Free PMC article.
References
-
- Swerissen H, Duckett S, Moran G. Mapping primary care in Australia. In: Grattan institute report no. 2018-09. Grattan institute, Melbourne, Australia. 2018. https://grattan.edu.au/wp-content/uploads/2018/07/906-Mapping-primary-ca.... Accessed 14 Jun 2019.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources